Newsroom
Sorted by: Latest
-
PROG Holdings, Inc. Investor Day Recap: Strategic Vision Outlined Including Selective Three-Year CAGR Financial Targets
SALT LAKE CITY--(BUSINESS WIRE)--PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Four Technologies, MoneyApp, and Purchasing Power, hosted its Investor Day in New York City on March 10, 2026. Members of the PROG leadership team outlined the Company’s strategy to evolve from a leasing-centric business to a multi-product consumer access platform and shared consolidated three-year compound annual growth rates expected for select financial metrics. “Investor Day...
-
The 2026 iHeartRadio Music Awards Airing Thursday, March 26 on FOX to Feature Performances by Alex Warren, Lainey Wilson, Ludacris, RAYE, TLC, En Vogue, Salt-N-Pepa and More Live from Dolby Theatre in Los Angeles
NEW YORK--(BUSINESS WIRE)--iHeartMedia and FOX Entertainment today announced that the 2026 iHeartRadio Music Awards will feature performances by Alex Warren, Lainey Wilson, Ludacris, RAYE, and performing for the first time together TLC, Salt-N-Pepa and En Vogue. Ludacris will host the annual event and also receive the 2026 iHeartRadio Landmark Award. Additionally, Miley Cyrus will be honored with the 2026 iHeartRadio Innovator Award and Alex Warren will receive the 2026 iHeartRadio Breakthrough...
-
隨著消費者更加關注日常健康,Haleon強化對中國市場的承諾
上海--(BUSINESS WIRE)--(美國商業資訊)-- 專注于提升日常健康的消費健康公司Haleon將投資6500萬英鎊,在上海新建一座現代化口腔健康生產基地。該基地將支援其口腔護理產品組合——包括全球品牌Sensodyne和parodontax——進軍中國快速成長的中級和次級城市。當地收入提升、日常健康意識強化,以及對可信品牌產品的偏好改變,正在重塑消費者行為。 在這一趨勢下,越來越多的消費者將預防性口腔護理納入日常自我護理流程,對頂級、有科學依據的解決方案需求快速成長。此次投資將強化Haleon的本地生產布局,協助企業在這一極具活力的市場把握長期成長機會。 中國是全球最大的牙齦健康市場,規模約達8.6億英鎊。中國超過70%的成年人存在不同程度的牙齦問題,且對牙齦出血、紅腫、敏感等症狀的認知不斷提升,為經過臨床驗證的牙齦健康產品帶來龐大市場商機。 Haleon成長最快的口腔健康品牌parodontax是中國首款經臨床驗證、能夠分解頑固牙菌斑、從根源改善牙齦出血的牙膏,而牙菌斑是引發牙齦疾病的主要原因。然而,其核心活性成分碳酸氫鈉帶來的獨特感官體驗,與許多口味更甜或更偏花香的本...
-
CoreWeave 48 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against CoreWeave, Inc. - CRWV
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against CoreWeave, Inc. (NasdaqGS: CRWV), if they purchased or otherwise acquired the Company’s securities between March 28, 2025 and December 15, 2025, inclusive (the “Class Period”). This action is pending in the U...
-
Salesforce Prices Public Offering of Senior Notes
SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that it has priced an underwritten offering (the “offering”) in aggregate principal amount of $25 billion in senior notes (the “notes”). The offering is expected to close on March 13, 2026, subject to the satisfaction of customary closing conditions. Salesforce intends to use all of the net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses payable by Sa...
-
Resumen: Eurofins Biomnis lanza un nuevo método clínico LC-MS/MS para la detección de la toxina cereulida en muestras de heces
LYON, Francia--(BUSINESS WIRE)--Eurofins Biomnis, proveedor europeo líder en servicios especializados de diagnóstico clínico y parte de la red internacional de laboratorios Eurofins, anuncia el desarrollo y la validación satisfactorios de un nuevo método de cromatografía líquida acoplada a espectrometría de masas en tándem (LC-MS/MS) para la detección y cuantificación de la toxina cereulida en muestras de heces humanas. Esta innovación destaca la innovación diagnóstica de Eurofins Biomnis y su...
-
Eurofins Biomnis führt eine neue klinische LC-MS/MS-Methode zum Nachweis von Cereulid-Toxin in Stuhlproben ein
LYON, Frankreich--(BUSINESS WIRE)--Eurofins Biomnis, ein führender europäischer Anbieter von spezialisierten klinischen Diagnostikdienstleistungen, der zum globalen Netzwerk der Eurofins-Labore gehört, kündigt die erfolgreiche Entwicklung und Validierung einer neuen Flüssigchromatographie-Tandem-Massenspektrometrie-Methode (Liquid Chromatography Tandem Mass Spectrometry, LC-MS/MS) zum Nachweis und zur Quantifizierung von Cereulid-Toxin in menschlichen Stuhlproben an. Diese Innovation unterstrei...
-
Riassunto: Eurofins Biomnis lancia il nuovo metodo clinico LC‑MS/MS per il rilevamento della tossina cereulide nei campioni fecali
LIONE, Francia--(BUSINESS WIRE)--Eurofins Biomnis, azienda europea leader nella fornitura di servizi specializzati di diagnostica clinica e parte della rete globale di laboratori Eurofins, annuncia il successo dello sviluppo e della convalida di un nuovo metodo di spettrometria di massa tandem e cromatografia liquida (LC‑MS/MS) per il rilevamento e la quantificazione della tossina cereulide in campioni fecali umani. Questa innovazione sottolinea la novità diagnostica di Eurofins Biomnis, nonché...
-
Samenvatting: Eurofins Biomnis introduceert nieuwe klinische LC-MS/MS-methode voor de detectie van cereulidetoxine in ontlastingmonsters
LYON, Frankrijk--(BUSINESS WIRE)--Eurofins Biomnis, een toonaangevende Europese aanbieder van gespecialiseerde klinische diagnostische diensten en onderdeel van het wereldwijde netwerk van Eurofins-laboratoria, kondigt de succesvolle ontwikkeling en validatie aan van een nieuwe vloeistofchromatografie-tandem massaspectrometrie (LC-MS/MS)-methode voor de detectie en kwantificering van cereulidetoxine in menselijke ontlastingmonsters. Deze innovatie onderstreept de diagnostische innovatie van Eur...
-
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Trip.com Group Limited Investors – TCOM
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Trip.com Group Limited (NASDAQ: TCOM) between April 30, 2024 and January 13, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Trip.com investors under the federal securities laws. To join the Trip.com class action, go to https://rosenlegal.com/submit-form/?case_id=50668 or call Phillip Ki...